Meet over 65 universities on 27 & 28 April > REGISTER NOW
Coventry University Featured PhD Programmes
University of Reading Featured PhD Programmes

Second generation nano-carriers for pancreatic cancer therapy

Department of Pure and Applied Chemistry

Dr Clare Hoskins Applications accepted all year round Self-Funded PhD Students Only
Glasgow United Kingdom Biomedical Engineering Cancer Biology Materials Science Pharmaceutical Chemistry Pharmacy

About the Project

Hybrid iron oxide-gold nanoparticles have been shown to have great potential as theranostic agents for cancer therapy. The iron oxide core can be used for diagnostic imaging using MRI whilst the gold surface possesses unique optimal properties. When gold nanoparticles or nano-shells are exposed to laser irradiation, they both refract and absorb the light energy and rapidly convert it into heat. This can be exploited as a trigger for drug release.

Our group have shown that hybrid iron oxide-gold nanoparticles can be surface modified with drug molecules through thermally labile mechanisms [1,2]. In our previous work we shown that drug attachment can be reversed at elevated temperatures in order to release [1,2]. Hence, this system can act as a controlled delivery system by activation (and heat stimulation) using a laser.

 In this project we would like to use this established chemistry in order to form a range of second generation particles exploiting combined therapies of anticancer drugs for pancreatic cancer treatment.

Techniques used:

Chemical synthesis, HPLC, FTIR, ICP, photon correlation spectroscopy, transmission electron microscopy, biological testing in cancer models

Funding Notes

Please note, this advert is for self-funded students only. Students will be liable for the cost of University registration & bench fees as well as their own living costs. Students from all parts of the world are welcome to apply.


[1] Oluwasanmi A, Al-Shakarchi W, Manzur A, Aldebasi MH, Elsini RS, Albusair MK, Haxton KJ, Curtis ADM, Hoskins C. 2017. Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy. J Control Release, vol. 266, 355-364.
[2] Malekigorji M, Alfahad M, Kong Thoo Lin P, Jones S, Curtis A, Hoskins C. 2017. Thermally triggered theranostics for pancreatic cancer therapy. Nanoscale, vol. 9(34), 12735-12745.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here

The information you submit to University of Strathclyde will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

* required field

Your enquiry has been emailed successfully

Search Suggestions

Search Suggestions

Based on your current searches we recommend the following search filters.

FindAPhD. Copyright 2005-2021
All rights reserved.